Myhibbin 200 mg/mL oral suspension Images
Generic Name: mycophenolate mofetil
This medication has been identified as Myhibbin 200 mg/mL oral suspension. It is supplied by Azurity Pharmaceuticals, Inc.
Myhibbin is used in the treatment of Organ Transplant, Rejection Prophylaxis and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Myhibbin 200 mg/mL oral suspension is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication

Myhibbin
- Generic Name
- mycophenolate mofetil
- Strength
- 200 mg/mL oral suspension
- Availability
- Prescription only
- Drug Class
- Selective immunosuppressants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Azurity Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 24338-0018
See also:
CellCept
Cellcept (mycophenolate mofetil) is used to prevent rejection of a kidney, liver, or heart ...
Imuran
Imuran is used for atopic dermatitis, autoimmune hepatitis, chronic active hepatitis, chronic ...
Mounjaro
Mounjaro is used for type 2 diabetes to help lower blood sugar levels. Mounjaro has also been shown ...
Prograf
Prograf is used to prevent your body from rejecting a heart, liver, or kidney transplant. Learn ...
Cytoxan
Cytoxan is used for acute lymphocytic leukemia, acute nonlymphocytic leukemia, breast cancer ...
Envarsus XR
Envarsus XR is used for organ transplant, rejection prophylaxis
Rapamune
Rapamune (sirolimus) is used to prevent rejection in people who have received a kidney transplant ...
Afinitor
Afinitor prevents the growth of cancer cells and is used to treat advanced kidney cancer. Learn ...
Neoral
Neoral is used for organ transplant, rejection prophylaxis, psoriasis, rheumatoid arthritis
Sandimmune
Sandimmune is used for organ transplant, rejection prophylaxis
More about Myhibbin (mycophenolate mofetil)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: selective immunosuppressants
- Breastfeeding
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.